1636 материалов по теме, собраны автоматически из проверенных источников
Roswell Park-Led Study Shows Promise for New Targeted Combination in People With Relapsed AML Roswell Park Comprehensive Cancer Center
Scientists at St. Jude Children's Research Hospital have shown that specific brain cells respond differently to H3.3 K27M, a mutation in the histone H3.3 protein that drives many cases of diffuse midline glioma (DMG), depending on the cells' location in the developing brain. These findings help explain why DMG, a…
In March 2020, as COVID-19 surged around the globe, Dolly Parton announced that she was making a $1 million donation to Vanderbilt University Medical Center to support research into treatments for the new coronavirus. The university later confirmed that the money was used to create the Dolly Parton COVID-19 Research…
A soot-caked helmet and grimy turnout gear have long been symbols of grit and experience among American firefighters. Yet exposure to contaminated equipment can increase the risk of cancer. Now, attitudes toward protective wear and other safety measures may be shifting in California firehouses. A new study led by…
NIH awards $7.5 million to study whether “forever chemicals” increase the risk of liver and endometrial cancers Keck School of Medicine of USC
Dr. Gary R. Morrow, a Pioneer in Cancer Research, Dies at 82 The ASCO Post
Cancer Survivors’ Follow-Up Oncology Visits Shifted to Primary Care, Study Finds Bioengineer.org
Research Spotlight: Highlights from the AACR Drug Discovery and Development Conference Pancreatic Cancer Action Network
The percentage of oral targeted anticancer drugs used for indications with label-documented evidence of survival benefit increased between 2016 and 2021, according to a review of claims data from a large national insurer. However, researchers still observed what they called “significant” use of — and spending on —…
Pershing Square Sohn Cancer Research Alliance Cancer Prize 2027 Oncodaily
In a new study published in Nature Communications, Boston Children's Hospital researchers identified a new target responsible for scar formation in the bone marrow of patients with a type of blood cancer known as myelofibrosis. Combining traditional myelofibrosis therapy with drugs that block scar formation may be a…
Patients with sickle cell disease are often hesitant to undergo transformative gene therapy—the current lengthy process requires multiple hospital visits to collect enough stem cells. Researchers from Boston Children's Hospital have helped smooth the road to gene therapy with a new approach that collects enough of the…
Scientists at St. Jude Children's Research Hospital have discovered that removing the gene for Regnase-1 from engineered immune cells makes them more effective at treating relapsed osteosarcoma. There is a great clinical need for new therapies for childhood osteosarcoma, for which there are very few effective…
Top 10 Cancer Research Grants Open to Researchers Worldwide Oncodaily